TET2 and acute myeloid leukemia: Regarding the controversial results of TET mutations on prognosis, Liu WJ et al. performed a meta-analysis including 2552 patients who concluded that TET2 mutations appear to be a poor prognostic indicator in both cytogenetically normal (CN)-AML patients and in a subgroup of patients with favorable/moderate class I risk genotypes [32].